Filter
3336
Text search:
Vaccines
Featured
Recommendations
354
New Publications
770
Language
Document type
No document type
1349
Studies & Reports
627
Guidelines
531
Fact sheets
207
Strategic & Response Plan
192
Manuals
177
Situation Updates
65
Training Material
58
Resource Platforms
46
Videos
39
Infographics
19
Brochures
16
Online Courses
10
Countries / Regions
Global
196
India
106
Kenya
82
Liberia
69
Latin America and the Carribbean
67
Congo, Democratic Republic of
65
Nigeria
64
Sierra Leone
62
Africa
62
Uganda
60
South Africa
58
Ethiopia
53
Nepal
50
Western and Central Europe
45
Syria
41
Brazil
40
Ghana
35
Rwanda
35
Ukraine
33
Malawi
32
Zambia
31
Philippines
29
West and Central Africa
29
Russia
29
Bangladesh
28
East and Southern Africa
28
Middle East and North Africa
27
Guinea
26
Namibia
26
Tanzania
25
Zimbabwe
23
Haiti
22
South Sudan
22
Germany
22
South–East Asia Region
21
Myanmar / Burma
20
Venezuela
19
Senegal
17
Mozambique
17
Lesotho
16
Yemen
16
Eastern Europe
16
Cameroon
15
Pakistan
15
Burkina Faso
14
Cambodia
13
Asia
13
Botswana
12
Eastern Europe and Central Asia
12
Indonesia
11
Afghanistan
9
Central African Republic
9
Western Pacific Region
9
Argentina
8
Colombia
8
Madagascar
8
Chile
8
Paraguay
8
Niger
7
Lebanon
7
China
7
Sudan
7
Somalia
6
Benin
6
Eswatini/ Swaziland
6
Burundi
6
Mali
5
Peru
5
Moldova
5
Vietnam
5
Côte d’Ivoire / Ivory Coast
4
USA
4
Togo
4
Iraq
4
Jordan
4
Turkey
4
Chad
4
Bolivia
4
United Kingdom
4
Guinea-Bissau
3
Ecuador
3
El Salvador
3
Angola
3
Mexico
3
Albania
3
Laos
3
Congo-Brazzaville
3
Iran
3
France
3
Saudi Arabia
2
Thailand
2
Papua New Guinea
2
Nicaragua
2
Sri Lanka
2
Fiji
2
Bulgaria
2
Spain
2
Morocco
1
Egypt
1
Switzerland
1
Hungary
1
Honduras
1
Libya
1
Guatemala
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Romania
1
Slovakia
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
South Korea
1
Belarus
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
1207
Clinical Guidelines
269
Women & Child Health
161
Public Health
156
Key Resources
131
Pharmacy & Technologies
47
Capacity Building
30
Annual Report MEDBOX
2
Toolboxes
COVID-19
736
AMR
156
Ebola & Marburg
155
HIV
126
TB
120
Rapid Response
116
NTDs
107
Pharmacy
93
Health Financing Toolbox
90
Global Health Education
78
Conflict
77
Planetary Health
69
Malaria
61
Refugee
58
Cholera
57
Caregiver
56
Polio
51
2.0 Rapid Response
50
Mental Health
46
Natural Hazards
26
Zika
23
NCDs
19
Disability
18
Specific Hazards
12
Typhoon
2
COVID-19 Vaccination in the Americas
recommended
On March 1, 2021, the countries of the Americas began receiving vaccines through the COVAX Mechanism, an unprecedented global effort between CEPI, Gavi, Unicef, PAHO, and WHO to ensure equitable access to immunization throughout the world. The PAHO
...
Exciting news this week with @Pfizer reporting their mRNA vaccine is 90% effective, based on their Phase III clinical trial data. Dr. Tom looks inside the virus to break down how mRNA vaccines work, and whether news this promising means we can final
...
Podcast: Why is Dengue fever spreading to places it did not exist before? What are the symptoms and treatments? What about vaccines? Dr Raman Velayudhan explains in Science in 5.
Learn about the science behind the new coronavirus vaccine made by Pfizer. This video goes over how vaccines work, and how the Pfizer vaccine is a bit different from most other virus vaccines.
Social and behavior change (SBC) professionals have often been tasked to find ways to influence knowledge, attitudes, and practices, about vaccines. Now that the COVID-19 vaccines are becoming avail
...
14 July 2021 This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s
...
Join the campaign to call on countries and companies to ensure that by the time World Health Day arrives on 7 April, COVID-19 vaccines are being administered in every country, as a symbol of hope for overcoming both the pandemic and the inequalities
...
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limited. It provides a values foundation for the objectives of COVID-19 vaccination programmes and links t
...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality.
...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT
...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub
...
An estimated 59 000 people die from rabies each year. That’s one person every nine minutes of every day, 40% of whom are children living in Asia and Africa. As dog bites cause almost all human cases, we can prevent rabies deaths by increasing awareness, vaccinating dogs to prevent the disease at i
...
On 27 September 2024, the Ministry of Health of Rwanda confirmed the country’s first outbreak of Marburg virus disease (MVD), with health-care workers in Kigali particularly affected. While sporadic outbreaks have occurred in various parts of Africa since the first recognized cases in 1967, this o
...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos
...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector
...
Humanitarian emergencies result in a breakdown of critical health-care services and often make vulnerable communities dependent on external agencies for care. In resource-constrained settings, this may occur against a backdrop of extreme poverty, malnutrition, insecurity, low literacy and poor infra
...
Version 3 Dec. 2020
The COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT)2, developed by WHO in collaboration with PAHO is a tool for the national authorities, that allows for the establishment of a roadmap and to monitor progress in the preparation of the activities related to the in
...
Dengue is a significant public health problem. There are four dengue virus serotypes identified; however, its diagnosis is difficult due to the existence of many viruses, bacteria, and parasites producing the same clinical presentation, being present in the same geographical area and even producing
...
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv
...
